G
GSK plc
GLAXFCIK 0001131399OTCLarge AcceleratedPharmaceutical PreparationsX0GB
Period
FY 2025
Revenue
—
Net Income
$6.29B
Total Assets
$61.12B
Equity
—
Shares Out
4.32B
Op. Cash Flow
—
Business
GSK plc is a foreign private issuer in Pharmaceutical Preparations, headquartered in the United Kingdom. Shares trade on NYSE under the ticker GSK.
Auto-generated from company profile
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $6.29B |
| Total assets | $61.12B |
| Total liabilities | $45.16B |
| Stockholders' equity | — |
| Operating cash flow | — |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro
Holdings (13F)
Portfolio as of 2025-12-31 · 15 positions
Reported AUM
$799.01M
Holdings
15
Top sector
$799.01M
Top sectors
| Sector | Value | % of portfolio |
|---|---|---|
| Uncategorized | $799.01M | 100.0% |
Top holdings
| Issuer | Ticker | Shares | Value | % |
|---|---|---|---|---|
| WAVE LIFE SCIENCES LTD | — | 18.25M | $310.18M | 38.8% |
| CRISPR THERAPEUTICS AG | — | 3.22M | $168.89M | 21.1% |
| BIONTECH SE | — | 889.8K | $84.71M | 10.6% |
| VIR BIOTECHNOLOGY INC | — | 8.55M | $51.56M | 6.5% |
| LYELL IMMUNOPHARMA INC | — | 1.51M | $46.56M | 5.8% |
| IDEAYA BIOSCIENCES INC | — | 1.33M | $46.09M | 5.8% |
| CYTOKINETICS INC | — | 340.4K | $21.63M | 2.7% |
| SPERO THERAPEUTICS INC | — | 9.19M | $21.41M | 2.7% |
| FULCRUM THERAPEUTICS INC | — | 1.79M | $20.20M | 2.5% |
| BICYCLE THERAPEUTICS PLC | — | 1.53M | $10.83M | 1.4% |